Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
2.490
+0.090 (3.75%)
Oct 24, 2025, 1:55 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2018FY 20172014 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 2014 - 2016
Innovative Cell-based Technologies
1.37M
Log In
Log In
Log In
Log In
Upgrade
Innovative Cell-based Technologies Growth
124.34%
Log In
Log In
Log In
Log In
Upgrade
License Fees
-
Log In
Log In
Log In
Log In
Upgrade
Product
-
Log In
Log In
Log In
Log In
Upgrade
Royalties
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2018FY 20172014 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 2014 - 2016
United States
1.37M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
124.34%
Log In
Log In
Log In
Log In
Upgrade
International
-
Log In
Log In
Log In
Log In
Upgrade
International Growth
-
Log In
Log In
Log In
Log In
Upgrade